title: Role of HIV-1 Vpr in AIDS pathogenesis: relevance and implications of intravirion, intracellular and free Vpr.
abstract: Vpr, a 14-kDa, 96 amino acid protein, is conserved among the primate lentiviruses HIV-1, HIV-2 and Simian Immunodeficiency virus supporting the notion that it plays an important role in virus life cycle in vivo. Vpr appears to have several functions including cell cycle arrest at G2 stage, apoptosis, nuclear localization, nuclear import of the pre-integration complex, cation selective channel activity and transcriptionally activate HIV-1 LTR and other heterologous promoters. Over the years, we have addressed several issues pertaining to Vpr including the amount of Vpr present in the virus particles and structure-function relationship of Vpr. Here, we have reviewed the sources of Vpr that may potentially contribute to the cytopathic features observed in the context of HIV-1 infection. There are three different sources of Vpr available in the infected individuals to initiate the pathogenic effects. These include cell-associated, virion-associated (infectious, infectious-non productive, and non-infectious defective viruses) and free Vpr (cell-free and virus-free). A potential role of Vpr in neuropathogenesis of HIV infection in CNS was also suggested by early studies demonstrating neurotoxicity of recombinant Vpr protein. Interestingly, free Vpr (cell-free and virus-free) has been demonstrated in the serum of HIV-1 infected individuals and in the CSF of AIDS patients with neurological dysfunctions. Based on the toxic effects of extra-cellular Vpr on cells noted in several studies, it is likely that free Vpr could contribute to the bystander cell depletion in lymphoid tissues, peripheral blood, and the CNS. These results led us to propose a model for the role of Vpr in AIDS pathogenesis.
authors.affiliation: Department of Microbiology and Immunology, Kimmel Cancer Center, Thomas Jefferson University, 1020 Locust Street, JAH Rm. 461, Philadelphia, PA 19107, USA.
authors.forename: Parithosh K
authors.initials: PK
authors.lastname: Tungaturthi
authors.forename: Bassel E
authors.initials: BE
authors.lastname: Sawaya
authors.forename: Satya P
authors.initials: SP
authors.lastname: Singh
authors.forename: Brian
authors.initials: B
authors.lastname: Tomkowicz
authors.forename: Velpandi
authors.initials: V
authors.lastname: Ayyavoo
authors.forename: Kamel
authors.initials: K
authors.lastname: Khalili
authors.forename: Ronald G
authors.initials: RG
authors.lastname: Collman
authors.forename: Shohreh
authors.initials: S
authors.lastname: Amini
authors.forename: Alagarsamy
authors.initials: A
authors.lastname: Srinivasan
mesh_terms: D000163:Acquired Immunodeficiency Syndrome / Q000503:physiopathology* / Q000821:virology; D000818:Animals; D016336:Gene Products, vpr / Q000502:physiology*; D015658:HIV Infections / Q000503:physiopathology / Q000821:virology; D015497:HIV-1 / Q000472:pathogenicity; D006801:Humans; D008954:Models, Biological; D054325:vpr Gene Products, Human Immunodeficiency Virus
chemical_list: D016336:Gene Products, vpr; D054325:vpr Gene Products, Human Immunodeficiency Virus